Trial · NCT02908685
Adverse event totals45
The totals the trial posted for each group.
1 to 20 of 45
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Part 1 Group A: Adolescents and Adults (3 mg Risdiplam) | 0 | 10 |
| Total, all-cause mortality | Part 1 Group A: Adolescents and Adults (5 mg Risdiplam) | 0 | 10 |
| Total, all-cause mortality | Part 1 Group A: Adolescents and Adults (Placebo-Control Period Pooled) | 0 | 6 |
| Total, all-cause mortality | Part 1 Group B: Children (0.02 mg/kg Risdiplam) | 0 | 7 |
| Total, all-cause mortality | Part 1 Group B: Children (0.05 mg/kg Risdiplam) | 0 | 14 |
| Total, all-cause mortality | Part 1 Group B: Children (0.15 mg/kg Risdiplam) | 0 | 21 |
| Total, all-cause mortality | Part 1 Group B: Children (0.25 mg/kg Risdiplam) | 0 | 7 |
| Total, all-cause mortality | Part 1 Group B: Children (Placebo-Control Period Pooled) | 0 | 10 |
| Total, all-cause mortality | Part 1 Group A: OLE | 0 | 20 |
| Total, all-cause mortality | Part 1 Group B: OLE | 0 | 31 |
| Total, all-cause mortality | Part 2 Placebo-Controlled: Risdiplam | 0 | 120 |
| Total, all-cause mortality | Part 2 Placebo-Controlled: Placebo | 0 | 60 |
| Total, all-cause mortality | Part 2 OLT: Risdiplam/Risdiplam | 0 | 117 |
| Total, all-cause mortality | Part 2 OLT: Placebo/Risdiplam | 0 | 59 |
| Total, all-cause mortality | Part 2 OLE: Risdiplam | 1 | 175 |
| Total, other adverse events | Part 1 Group A: Adolescents and Adults (3 mg Risdiplam) | 9 | 10 |
| Total, other adverse events | Part 1 Group A: Adolescents and Adults (5 mg Risdiplam) | 8 | 10 |
| Total, other adverse events | Part 1 Group A: Adolescents and Adults (Placebo-Control Period Pooled) | 4 | 6 |
| Total, other adverse events | Part 1 Group B: Children (0.02 mg/kg Risdiplam) | 6 | 7 |
| Total, other adverse events | Part 1 Group B: Children (0.05 mg/kg Risdiplam) | 12 | 14 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02908685/event-totals